Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05430022 · ClinicalTrials.gov registry record · NA
Group Depression Treatment for Autistic Youth
A NA study, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 48
- Enrollment target
NCT05430022 is a NA study that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 48 participants.
The verdict
NCT05430022, a NA study, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 48 participants
- Enrollment target
Study Summary
Higher rates of depression are reported by autistic adolescents as compared to their non-autistic peers, which is problematic given adverse outcomes (e.g., negative self-esteem, lower academic performance) that are associated with depression. Despite the alarming rates of depression in autistic youth and associated safety concerns, few treatments have been developed. In this study, we investigate the feasibility, acceptability, and preliminary efficacy of an autism-adapted group cognitive-behavioral treatment for autistic adolescents (11-17 years old; middle and high school) in a pilot, nonrandomized trial. Specifically, we aim to increase adolescents' perception and understanding of self, including autistic identity, in order to treat depression. Intervention design and implementation were guided by autistic self-advocates and parents.
Interventions
- BEHAVIORAL Autism-adapted Group Cognitive Behavioral Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2021-07-21 |
| Est. Completion | 2023-04-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05430022
The ClinicalTrials.gov registry entry for NCT05430022 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Autism-adapted Group Cognitive Behavioral Therapy is the first listed.
NCT05430022 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05430022 about?
NCT05430022 is a clinical study titled "Group Depression Treatment for Autistic Youth". Higher rates of depression are reported by autistic adolescents as compared to their non-autistic peers, which is problematic given adverse outcomes (e.g., negative self-esteem, lower academic performance) that are associated with depression. Despite the alarming rates of depression in autistic yout...
What is the current status of trial NCT05430022?
This trial is currently completed. It is a NA study. The enrollment target is 48 participants. The study started on 2021-07-21. Estimated completion is 2023-04-03.
What interventions are being tested in trial NCT05430022?
The interventions under investigation include: Autism-adapted Group Cognitive Behavioral Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT05430022?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.